• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典人群中更年期症状的患病率和严重程度以及不同治疗方案的使用情况。

The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population.

作者信息

Stadberg E, Mattsson L A, Milsom I

机构信息

Department of Obstetrics and Gynecology, East Hospital, University of Göteborg, Sweden.

出版信息

Acta Obstet Gynecol Scand. 1997 May;76(5):442-8. doi: 10.3109/00016349709047826.

DOI:10.3109/00016349709047826
PMID:9197447
Abstract

OBJECTIVES

To determine (i) the prevalence and severity of climacteric symptoms, and (ii) the prevalence of treatment for climacteric complaints, in a population based, random sample of Swedish women aged 46-62 years.

MATERIAL AND METHODS

A random sample of 5990 women from the birth cohorts 1946, 1942, 1938, 1934 and 1930, resident in the city of Göteborg, was obtained from the population register. The women were invited by letter to complete a questionnaire concerning general health, reproductive history, climacteric symptoms (severity graded on a scale 0,1,2,3) and the treatment of climacteric complaints. The overall response rate was 76%.

RESULTS

The prevalence of climacteric symptoms was as follows: vasomotor symptoms 53%, depression/irritability 57%, sleeping disturbance 52%, muscle/joint pain 57%, loss of libido 37% and vaginal dryness 21%. Hormone replacement therapy (HRT) with medium potency estrogens was currently being used by 13.4% and 7.7% were using low potency estrogens. Medium potency estrogens had previously been used by 14% and 6% had used low potency estrogens. HRT was reported to be effective against the most common climacteric complaints in 70%-90%. Non-hormonal treatment regimens had been used by 45% of the women and 31-63% reported a positive effect on climacteric symptoms.

CONCLUSIONS

Although the majority of peri- and postmenopausal women reported suffering from climacteric complaints only 21% were current users of estrogens. Non-hormonal treatment modalities had been used by 45% of the women and were reported to have a good effect on climacteric symptoms in 45% compared to up to 90% of the HRT users.

摘要

目的

在瑞典46 - 62岁女性的基于人群的随机样本中,确定(i)更年期症状的患病率和严重程度,以及(ii)更年期主诉的治疗患病率。

材料与方法

从哥德堡市的人口登记册中获取了出生队列1946、1942、1938、1934和1930年的5990名女性的随机样本。通过信件邀请这些女性填写一份关于一般健康、生殖史、更年期症状(严重程度按0、1、2、3级评分)和更年期主诉治疗的问卷。总体回复率为76%。

结果

更年期症状的患病率如下:血管舒缩症状53%,抑郁/易怒57%,睡眠障碍52%,肌肉/关节疼痛57%,性欲减退37%,阴道干燥21%。目前13.4%的女性正在使用中效雌激素进行激素替代疗法(HRT),7.7%的女性正在使用低效雌激素。以前有14%的女性使用过中效雌激素,6%的女性使用过低效雌激素。据报告,HRT对70% - 90%的最常见更年期主诉有效。45%的女性使用过非激素治疗方案,31 - 63%的女性报告对更年期症状有积极影响。

结论

尽管大多数围绝经期和绝经后女性报告有更年期主诉,但只有21%的女性目前在使用雌激素。45%的女性使用过非激素治疗方式,据报告,与高达90%的HRT使用者相比,45%的非激素治疗使用者对更年期症状有良好效果。

相似文献

1
The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population.瑞典人群中更年期症状的患病率和严重程度以及不同治疗方案的使用情况。
Acta Obstet Gynecol Scand. 1997 May;76(5):442-8. doi: 10.3109/00016349709047826.
2
A longitudinal population study of climacteric symptoms and their treatment in a random sample of Swedish women.一项针对瑞典女性随机样本的更年期症状及其治疗的纵向人群研究。
Climacteric. 2004 Dec;7(4):357-65. doi: 10.1080/13697130400001786.
3
Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.态度、知识及激素替代疗法使用情况的变化:一项对两个间隔6年的随机样本的比较研究。
Acta Obstet Gynecol Scand. 2005 Apr;84(4):395-401. doi: 10.1111/j.0001-6349.2005.00725.x.
4
[Use of estrogen replacement therapy and alternative therapies among Norwegian women aged 50-69].
Tidsskr Nor Laegeforen. 2006 Jan 26;126(3):318-20.
5
Womens attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study.
Maturitas. 1997 Jun;27(2):109-16. doi: 10.1016/s0378-5122(97)00035-2.
6
Hormone replacement therapy and previous use of oral contraceptives among Swedish women.瑞典女性中的激素替代疗法及既往口服避孕药使用情况
Maturitas. 1996 Nov;25(3):193-9. doi: 10.1016/s0378-5122(96)01065-1.
7
Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.激素替代疗法使用的重要因素:一项基于瑞典女性人群的研究。隆德地区女性健康(WHILA)研究。
Menopause. 2000 Jul-Aug;7(4):273-81.
8
Factors associated with climacteric symptoms and the use of hormone replacement therapy.与更年期症状及激素替代疗法使用相关的因素。
Acta Obstet Gynecol Scand. 2000 Apr;79(4):286-92.
9
Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.丹麦45至65岁女性的激素替代疗法:患病率、决定因素及依从性。
Obstet Gynecol. 1997 Aug;90(2):269-77. doi: 10.1016/S0029-7844(97)00264-0.
10
The climacteric among South-American women, who immigrated to Sweden and age-matched Swedish women.
Maturitas. 1995 Jan;21(1):3-6. doi: 10.1016/0378-5122(94)00855-2.

引用本文的文献

1
Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women's General Hospital.唑吡坦与黑种草籽治疗妇女总医院绝经后女性睡眠障碍和血管舒缩症状的疗效比较
J Family Reprod Health. 2020 Sep;14(3):186-191. doi: 10.18502/jfrh.v14i3.4672.
2
Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial.异黄酮大豆蛋白补充剂对健康绝经后妇女动脉粥样硬化进展的影响:一项随机对照试验。
Stroke. 2011 Nov;42(11):3168-75. doi: 10.1161/STROKEAHA.111.620831. Epub 2011 Sep 8.
3
Vulvovaginal atrophy.
外阴阴道萎缩。
Mayo Clin Proc. 2010 Jan;85(1):87-94. doi: 10.4065/mcp.2009.0413.
4
Age-specific symptom prevalence in women 35-64 years old: a population-based study.35至64岁女性特定年龄症状患病率:一项基于人群的研究。
BMC Public Health. 2009 Jan 26;9:37. doi: 10.1186/1471-2458-9-37.
5
Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.1990 - 1995年在一家管理式医疗组织中绝经后激素替代疗法的使用 prevalence 和持续时间
J Gen Intern Med. 2000 Aug;15(8):542-50. doi: 10.1046/j.1525-1497.2000.03499.x.